Conditions: Acne Vulgaris
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 420
Healthy volunteers: no

Brief summary:
The objectives of this study are to assess the safety and efficacy DRM01 Topical Gel compared to vehicle in patients with acne vulgaris.

Detailed description:

Arms:
arm 1: Olumacostat Glasaretil Gel, Vehicle, applied once daily to the face for 12 weeks arm 2: Olumacostat Glasaretil Gel, Vehicle, applied twice daily to the face for 12 weeks arm 3: Olumacostat Glasaretil Gel, 4.0%, applied once daily to the face for 12 weeks arm 4: Olumacostat Glasaretil Gel, 7.5%, applied once daily to the face for 12 weeks arm 5: Olumacostat Glasaretil Gel, 7.5%, applied twice daily to the face for 12 weeks

Interventions: intervention 1: Olumacostat Glasaretil intervention 2: Vehicle
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: